iron dextran and b12 injectable IRETON | VIT Iron Hydergenated Dextran Injectable for
Description
Daratumumab earned approval for monotherapy due to its efficacy, safety profile and durable responses demonstrated in the phase 1/2 GEN501 and the phase 2 SIRIUS clinical trials on heavily pretreated RRMM patients [71, 72]
Please contact us for your free weight loss consultation
Up to 15% 15%
No mental math at the bench
